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under theAbstract There is limited information on the causes of paediatric diarrhoea in Syd-
ney. This cross-sectional study used clinical and microbiological data to describe the
clinical features and pathogens associated with gastrointestinal illnesses for chil-
dren presenting to two major public hospitals in Sydney with diarrhoea, for the per-
iod January 2007–December 2010.
Of 825 children who tested positive for an enteric pathogen, 430 medical records
were reviewed. Adenovirus, norovirus and rotavirus were identified in 20.8%, 20.3%
and 21.6% of reviewed cases, respectively. Younger children were more likely to
have adenovirus and norovirus compared with rotavirus (P = 0.001). More viruses
were detected in winter than in the other three seasons (P = 0.001). Rotavirus pre-
sented a distinct seasonal pattern with the lowest rates occurring in the warm
months and peaking in the cooler months. Adenovirus showed a less consistent
monthly trend, and norovirus detection increased in the cooler months
(P = 0.008). A decline in the number of rotavirus cases was observed after mid-2008.2 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
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12 S. Fletcher et al.The majority of childhood diarrhoeal illnesses leading to hospital presentations in
Sydney are caused by enteric viruses with most infections following clear seasonal
patterns. However, a sustained decrease in the incidence of rotavirus infections
has been observed over the study period.
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Acute diarrhoeal illnesses continue to be an impor-
tant cause of morbidity in children, affecting both
developed and developing countries [1]. Enteric
viruses, especially rotavirus, have been recognised
as the leading cause of childhood diarrhoea world-
wide [1,2]. Several studies reveal that rotavirus,
norovirus, adenovirus and astrovirus are the main
viral causes of acute childhood diarrhoea [3]. Re-
ports from the United Kingdom have shown viral
agents responsible for up to 50% of all community-
acquired and health-care associated gastroenteri-
tis [4]. Australian data for all ages reveal that
enteric viruses, mainly norovirus and rotavirus,
are common causes of gastroenteritis, accounting
for about 15–18% of all gastroenteritis cases [5].
Nearly all children worldwide become infected
with rotavirus by their fifth birthday; with those
aged between 6 months and 2 years more suscepti-
ble to severe disease resulting in hospitalisations
[6]. The burden of rotaviral diarrhoea worldwide
has resulted in the World Health Organization
(WHO) placing priority on the development and dis-
tribution of rotavirus vaccines globally [7]. Norovi-
rus infections, on the other hand, are recognised as
a leading cause of epidemic gastroenteritis affect-
ing all age groups, with sporadic cases occurring
all year round with increased incidence observed
in colder months [8]. In contrast to rotavirus, noro-
virus is the principal cause of healthcare-associated
viral diarrhoea [9]. Enteric adenovirus types 40 and
41 and astrovirus are less frequently implicated,
but are also important causes of acute diarrhoeal
illnesses in sporadic and outbreak settings [9].
Over the last 15 years, great progress has been
made towards the development and introduction
of rotavirus vaccines, despite the withdrawal of
an early vaccine due to safety concerns [10]. Vac-
cination programmes are estimated to prevent
approximately 85–100% of hospitalisations due to
rotavirus at least 1 year following vaccination
[11]. The introduction of the rotavirus vaccine in
the United States of America (USA) in 2006 and in
Australia in 2007 has led to a dramatic reduction
in the incidence and number of hospitalisations
for acute gastroenteritis [12,13]. An American re-port projected that the administration of the rota-
virus vaccine at ages 2, 4 and 6 months would result
in an estimated 255,000 fewer physician visits;
137,000 fewer Emergency room visits; 44,000 few-
er hospitalisations; and 13 fewer deaths per year in
children aged <5 years [10].
The rotavirus vaccination programme was imple-
mented in the Australian National Immunisation
programme in the year 2007 [6]. Immunisation
against rotavirus using Rotarix at 2 and 4 months
of age started in the Northern Territory from Octo-
ber 2006, while universally funded immunisation
against rotavirus at 2 and 4 months of age
(Rotarix) or at 2, 4 and 6 months of age (Rotateq)
began from July 2007 in other States [6]. Immunisa-
tion or catch-up programmes for older children and
adults is not recommended in Australia [14].
Little is known about the risk factors of paediat-
ric gastrointestinal illnesses for children presenting
to hospital with diarrhoea in Sydney. Knowledge of
the actual causes and their prevalence is important
to inform prompt diagnosis and treatment and
evaluate the impact of the rotavirus vaccination
programme. This retrospective study utilises the
review of laboratory and hospital databases to de-
scribe the prevalence of diarrhoeal pathogens and
associated clinical features in children presenting
to hospital in urban Sydney up to 3 years after
widespread vaccine uptake.
2. Methods
2.1. 2.1.1. Study setting
Two large hospitals serving the paediatric popula-
tion of Sydney were included in the study; a major
general public hospital in South Western Sydney
(Hospital A) and a tertiary/quaternary paediatric
centre in the Sydney childrens hospital network
(Hospital B). Ethical approval was granted by the
Human Research Ethics Committees of both Hospi-
tals and the University of Technology, Sydney.
2.1.2. Microbiology methods
Both laboratories routinely test for enteric patho-
gens in patients presenting with gastrointestinal
symptoms. Both laboratories use the standard
2 Available at http://stattrek.com/Tables/Random.aspx.
Gastrointestinal pathogen distribution in symptomatic children in Sydney, Australia 13methods for the identification and isolation of en-
teric pathogens as described below.
2.1.3. Virology
Both laboratories conducted testing for adenovirus
and rotavirus routinely in all children 65 years of
age unless otherwise indicated or requested by
the clinician. However, Hospital A tested for noro-
virus on request or where outbreaks were sus-
pected. Hospital A tested for rotavirus, adenovirus
serotypes 40 and 41 and norovirus using the enzyme
immunoassay (EIA) method for each species,
respectively. Hospital B used the RIDA Quick Rotavi-
rus/Adenovirus Combi immunochromatographic
test (ICT) and the RIDASCREEN norovirus test
(EIA). All tests were conducted following the manu-
facturers recommendations. The adenovirus test
used at Hospital B detects all adenovirus serotypes,
and not just the enteric serotypes 40 and 41.
2.1.4. Bacteriology
Bacterial identification was done routinely in all
laboratories using standard culture methods.
Selective media (Xylose, Lysine Deoxycholate agar
[XLD]), Salmonella selective broth, Campylobacter
selective agar, and Yersinia selective agar were
inoculated for the detection of Salmonella spp.,
Shigella spp., Campylobacter spp. and Yersinia
enterocolitica. Detection of Aeromonas, Plesiomo-
nas and Vibrio spp. was attempted only on special
request, or where relevant clinical notes such as
overseas travel or seafood consumption were pro-
vided. Clostridium difficile testing was performed
using the EIA for diarrhoea greater than 3 days
after hospital admission, on special request, or
where relevant clinical notes were provided (e.g.
history of antibiotic use, chemotherapy or immu-
no-suppressed). In Hospital A, C. difficile toxin
testing was performed on one semi-formed/loose
sample if requested.
2.1.5. Parasitology
At both sites, direct microscopy was routinely per-
formed on all stool specimens for the detection of
ova, cysts, and parasites. However, concentration
techniques were performed only on special request
or when indicated by certain circumstances; e.g.
history of overseas travel or prolonged diarrhoeal
illness. At Hospital A, stool specimens are routinely
collected in sodium acetate acetic acid formalin
(SAF) fixative (Oxoid Australia), and direct wet
preparation microscopy was routinely performed
on all stool specimens. In the instances where no
clinical information was received and the patient
was an adult or age 610 years old, or the specimen
was not received in SAF, then a Giardia/Cryptospo-ridium screen enzyme immunoassay (EIA) (ProS-
pecTTM Giardia/Cryptosporidium Microplate Assay)
was performed. A 10% suspension of stool samples
was prepared in 10% formalin (for Giardia intesti-
nalis and Cryptosporidium) and the EIA was per-
formed in accordance with the manufacturers
instructions and without modification. A full COP
test was done on all positive microscopy and EIA re-
sults using an Iron haematoxylin stain with modi-
fied acid fast stain. A similar procedure was
employed for all stool specimens received at Hospi-
tal B, and samples positive by direct microscopy
are placed into SAF fixative followed by confirma-
tion by iron haematoxylin staining.
2.2. Medical record review
2.2.1. Selection criteria
The primary selection criteria were all children
aged 0–5 years seen in each hospital and/or its
affiliated clinics that had gastrointestinal symp-
toms and had a stool specimen testing positive
for an enteric organism. Patients presenting with
gastrointestinal symptoms including diarrhoea (de-
fined as the passing of three or more unformed
[loose, liquid, watery] stools within a 24-h period),
with or without fever, abdominal/colicky pain,
vomiting and nausea were included in the sample.
2.2.2. Sampling
Paediatric cases are a sub-group of a larger study
involving adults and adolescents/children. Children
with diarrhoea were identified from the microbiol-
ogy results based on date of birth and/or age
5 years or younger at the date when the sample
was tested. Laboratory data were then stratified
based on two seasons (Spring/Summer and Au-
tumn/Winter) in each year. Attempts were made
to review 100% (154/154) of medical records at
Hospital A and 50% (335/671) of records at Hospital
B, owing to a larger number of children being seen.
These proportions were chosen based on cost and
time constraints. Samples were randomly selected
using a random number generator.2 The medical
record charts were obtained for each case using
their unique medical record number (MRN), and
matched by date of visit/service date. Clinical
summaries were reviewed for signs and symptoms,
risk factors, diagnosis and treatment data.
2.3. Statistical methods
Analysis included the median, mean and standard
deviation (SD) for distribution of demographic
14 S. Fletcher et al.characteristics, clinical symptoms, proportion of
pathogens isolated amongst all positive cases,
association between clinical symptoms, season
and viral pathogens using Pearsons Chi-square
test. Odds Ratios (OR) and 95% confidence intervals
(95% CI) for the association between age and viral
agents detected were calculated using the binary
logistic regression model where the dependent var-
iable was each virus (rotavirus, adenovirus, norovi-
rus) coded as 1 = No, 2 = Yes, and age groups being
the independent variable, using the Enter method.
Statistical analyses were performed using PASW
Statistics Release version 18.0 [15].
3. Results
3.1. Demographics
A total of 825 children aged 0–5 years (154 at Hos-
pital A and 671 at Hospital B) who presented to the
hospitals had a stool specimen testing positive for
an enteric organism over the period January
2007–December 2010. From Hospital A, only 78%
(132/154) of cases were reviewed because the
remaining medical records were either not avail-
able, or the age of the subject could not be deter-
mined. Of the 335 (50%) cases selected from
Hospital B, only 89% (298/335) were reviewed due
to either unavailability of records or legal/ethical
reasons. The medical records for a total of 430 chil-
dren were reviewed from the two hospitals (see Ta-
ble 1). The median (LQ, UQ) age of children was 1.4
(0.8, 2.0) years [mean 1.6 years, SD 1.2]. There
were slightly more males (56%) than females.
3.2. Clinical profile
Of the children reviewed, 89% (382/430) had symp-
toms prior to admission for 1–4 days with a median
of 3 days and requiring admission for a median of
1 day. A total of 28% (120/430) of the children re-
quired admission to the emergency department
for two or more nights. Just over half (58%) of all
cases presented with elevated body temperature
[mean ± SD: 37.8 ± 1.2 C], ranging from 35.0 to
41.0 C. The majority of children, 68% (264/
430), presented with explosive or watery stools,
21% (90/430) had blood/mucous in their stools,
and 3% (11/430) experienced persistent diarrhoea
lasting for P14 days. Vomiting was frequently
experienced (68%, 293/430), followed by dehydra-
tion (31%, 132/430) and abdominal cramping/pain
(19%, 80/430). Other major signs and symptoms in-
cluded: anorexia (31%, 134/430), lethargy 38%
(165/430), and respiratory symptoms (25%, 106/430)
(Table 2).According to discharge coding, 79% (338/430) of
the children were classified on presentation with
an infectious gastrointestinal illness, 76% (323/
430) of cases had a principal diagnosis and 70%
(301/430) had an additional diagnosis of infectious
gastrointestinal illness. Co-morbidities were noted
in a few cases, including recent surgery 2% (10/
429), complications related to neonatal period 4%
(16/430) and cancer/lymphomas 3% (11/430).
About 20% (82/430) of cases had a family member
or close contact with gastrointestinal symptoms
around the same time of their illness that included
up to a week before or after onset. Prolonged anti-
biotic-therapy or chemotherapy was reported by
12% (53/429), but neither C. difficile antigens nor
toxins were detected in any of these cases. Only
6% (27/430) of cases developed diarrhoea 48 h or
more after hospitalisation, and significantly more
were infected with norovirus (56%, 15/27) com-
pared with rotavirus (33%, 9/27) and adenovirus
(11%, 3/27) (P = 0.022).
3.3. Pathogen distribution
There was near equal distribution of each viral
agent isolated as a percentage of the total patho-
gens isolated (Table 3). Overall, rotavirus was iden-
tified as a single pathogen in 22%, adenovirus in 21%
and norovirus in 20% of cases reviewed. However,
Table 4a shows that when laboratory results were
considered, there was slightly more rotavirus
(33.8% and 17.1%) isolated from cases at both hos-
pitals than adenovirus and norovirus. Campylobac-
ter spp. (11.0% and 27.1%) and non-typhoid
Salmonella spp. (14.9% and 22.2%) were the most
common bacteria isolated in both Hospitals A and
B, respectively. Giardia intestinalis was the most
common protozoa found in 3.2% and 3.7% of cases
in each hospital, respectively. Non-typhoid Salmo-
nella spp. and adenovirus were frequently found as
a second pathogen in a few cases (Table 4b). Infec-
tion with adenovirus and norovirus decreased with
increasing age (P = 0.001), but the opposite was
true for rotavirus (Fig. 1). The lowest rate of rota-
virus (12%) was observed in children under 1 year
old, and approximately half of the adenovirus
(52%) and norovirus (46%) cases were in children
under one year old (P = 0.001). The relationship be-
tween age and the three viral agents was examined
using a logistic regression model and adjusted for
seasonal variations. Children under 1 year old age
group were five to seven times more likely to have
adenovirus and norovirus, than rotavirus, Campylo-
bacter and Salmonella spp., isolated from their
stools. Children in the 1–2 years age group had
an increased risk of infection with norovirus (OR
Table 1 Total cases tested for enteric pathogens in children in two hospitals 2007–2010, Sydney.
Sampling details Hospital A Hospital B
Total specimens testeda 15,694 9239
Individual casesb 5020 5229
Total positives 971 932
Total negatives 4049 4297
Children 0–5 years (% of total) 868 (17.3%) 3910 (74.8%)
Total positives 154 (19.5) 671 (17.2)
Total negatives 714 3239
Reviewed N (%) 132 (78.1) 298 (44.4)
a Includes individuals who submitted multiple stool specimens.
b These are only individual cases (regardless of number of stool specimens) counted to get this number. Hospital A had 5020
individual cases, 868 of which were children 0–5 years. Hospital B had 5229 individual cases, 3910 of which were children 0–
5 years.
Table 3 Comparison of rate of enteric pathogens isolated from children in two hospitals.
Hospital A
n (%)
Hospital B n (%) Total (within pathogen)
n (%)
Rotavirus 47 (36) 51 (17) 98 (23)
Adenovirus 30 (23) 74 (25) 104 (24)
Norovirus 1 (1) 97 (32) 98 (23)
Other bacteriaa 52 (39) 71 (24) 121(28)
Other parasites 2 (2) 2 (1) 4 (1)
Adenovirus + rotavirus 2 (2) 3 (1) 5 (1)
Rotavirus + norovirus 0 (0) 1 (0.3) 1 (0.2)
% of Total (within hospital) 132 (31) 69 (297) 429 (100)
a Other-bacteria: Campylobacter sp. (61), Salmonella spp. (55) Shigella sp. (3), Clostridium difficile (3) and Yersinia entero-
colitica (4); Enteric protozoa: Blastocystis sp. (1), Giardia intestinalis (2), and Dientamoeba fragilis (1).
Table 2 Summary of clinical findings associated with diarrhoea in children.
Clinical symptoms
(N = 430)a
Hospital A n (%)
(N = 132)
Hospital B n (%)
(N = 298)
Total n (%) P, Pearsons
v2 (df)
Vomiting 103 (78) 190 (64) 293 (68) 0.003, 8.58(1)
Abdominal pain 29 (22) 17 (51) 80 (19) 0.149, 1.39(1)
Fever 96 (73) 51 (152) 248 (58) 0.001, 17.68(1)
Dehydration 52 (39) 27 (80) 132 (31) 0.007, 6.77(1)
Anorexia 76 (58) 20 (59) 135 (32) 0.001, 60.26(1)
Lethargy 52 (39) 38 (113) 165 (38) 0.772, 0.084(1)
Upper respiratory symptoms 18 (14) 30 (88) 106 (25) 0.001, 12.44(1)
a Reviewed 430 cases with one or more symptoms.
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children were less likely to have Campylobacter
(OR range 0.3 [95% CI = 0.1–0.6] to 0.6 [95%
CI = 0.3–1.2]) detected in their stools, and this risk
decreased further with decreasing age (P < 0.05).
The risk of infection with Salmonella spp. was sig-
nificantly less and consistent in children under
3 years old when compared with those 3–5 years
old (OR range 0.4 [95% CI = 0.2–0.9]; P < 0.05).Amongst the children infected with the three viral
agents, those with rotavirus were significantly
more likely to exhibit anorexia (P = 0.001) and leth-
argy (P = 0.005), whilst those with adenovirus were
more likely to exhibit respiratory symptoms; how-
ever, this relationship was not significant
(P = 0.603). There was no variation in symptom
profile between infection with Salmonella and
Campylobacter (Table 6).
Table 4a Prevalence of single enteric pathogens in children 0–5 years in Sydney, 2007–2010.
Organisms Hospital A Hospital B
Single pathogen n/868 % of Positive
cases (154)a
% of Specimen
tested (868)b
n/3910 % of Positive
cases (671)a
% of Specimen
tested (3910)b
Bacteria
Aeromonas spp. 0 0 0 3 0.4 0.1
Campylobacter 17 11.0 2.0 182 27.1 4.7
C. difficile 5 3.2 0.6 N/T N/T N/T
Salmonella enteric spp. 23 14.9 2.6 149 22.2 3.8
Salmonella typhi 0 0 0 3 0.4 0.1
Shigella 2 1.3 0.2 1 0.1 0.0
Yersinia enterocolitica 1 0.6 0.1 9 1.3 0.2
Viruses
Adenovirus 40 26.0 4.6 81 12.1 2.1
Norovirus 5 3.2 0.6 79 11.8 2.0
Rotavirus 52 33.8 6.0 115 17.1 2.9
Parasites
Blastocystis spp. 2 1.3 0.2 8 1.2 0.2
Cryptosporidium 1 0.6 0.1 7 1.0 0.2
Dientamoeba fragilis N/T N/T N/T 9 1.3 0.2
Giardia intestinalis 5 3.2 0.6 25 3.7 0.6
Schistosoma 1 0.6 0.1 N/T N/T N/T
N/T: tests were not conducted or organism not detected.
a The number of specimens positive for each pathogen was divided by the number of positive cases expressed as % of positive
cases.
b The number of specimens positive for each pathogen was divided by the number of specimens tested expressed as % of
specimens tested.
Table 4b Prevalence of multiple enteric pathogens in children 0–5 years in Sydney, 2007–2010.
Organisms Hospital A Hospital B
Co-infections Pathogen n % of Positive
cases (154)a
% of Specimen
tested (868)b
n % of Positive
cases (671)a
% of Specimen
tested (3910)b
Campylobacter spp. 3 1.9 0.3 20 3.0 0.5
Clostridium difficile 2 1.3 0.2 0.0 0.0 0.0
Salmonella enterica spp. 6 3.9 0.7 36 5.4 0.9
Salmonella typhi 0 0 0 1 0.1 0.0
Adenovirus 4 2.6 0.5 9 1.3 0.2
Norovirus 0 0 0 4 0.6 0.1
Rotavirus 0 0 0 26 3.9 0.7
Blastocystis spp. 1 0.6 0.1 2 0.3 0.1
Cryptosporidium 1 0.6 0.1 1 0.1 0.0
Dientamoeba fragilis 0 0 0 1 0.1 0.0
Giardia intestinalis 3 2.6 0.5 6 0.9 0.2
a The number of specimens positive for each pathogen was divided by the number of positive cases expressed as % of positive
cases.
b The number of specimens positive for each pathogen was divided by the number of specimens tested expressed as % of
specimens tested.
16 S. Fletcher et al.3.4. Seasonal distribution
Seasonal distribution of viral infections was as-
sessed. Overall, more viruses were isolated in win-
ter than in the other three seasons (v2 = 37.0(9);P = 0.001). Significantly more norovirus (41%) was
found in the winter followed by rotavirus (32%;
P = 0.001). In autumn, significantly more adenovi-
rus (49%) was isolated, whilst in the spring, rotavi-
rus (48%) dominated. Rotavirus accounted for the
Figure 1 Age distribution of viral pathogens associated with childhood diarrhoea in Sydney, 2007–2010.
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The distribution of the three viruses by month of
detection is presented in Fig. 2. Rotavirus pre-
sented a distinct pattern, with the lowest numbers
detected in the warmer months and gradually
increasing and peaking in the cooler months. Ade-
novirus on the other hand showed a less consistent
monthly trend; however, a gradual increase in lab-
oratory confirmed cases was observed in the cooler
months of 2010. An increase in the number of noro-
virus detected was also observed in the cooler
months of 2008–2010.
3.5. Management and treatment of
diarrhoea
Generally speaking, children are managed conser-
vatively; however, in cases where there were pro-
longed vomiting, dehydration, lethargy and
anorexia, children received rehydration therapy.
It was observed that IVF was given only in cases
of dehydration or when children did not tolerate
oral intake or nasogastric tube (NG) feeds.
4. Discussion
This four-year multi-centre retrospective study
used clinical and microbiological data to describe
the clinical features and pathogens associated with
gastrointestinal illnesses in children presenting to
two major public hospitals in Sydney for the period
January 2007–December 2010. The study found
that viral pathogens are the major causes of child-
hood diarrhoea in Sydney, accounting for nearly
two thirds of cases. Campylobacter spp. and non-
typhoid Salmonella spp. – two common food-bornepathogens – were other common causes of diar-
rhoea in children.
A review of clinical and laboratory records
showed nearly equal distribution of rotavirus
(21.6% and 2.9%), adenovirus (20.6% and 2.1%)
and norovirus (20.3% and 2.0%) isolated from chil-
dren, which is rather unusual. In childhood diar-
rhoea, rotavirus usually dominates in sporadic
cases, with norovirus being more prominent in
outbreak settings [16]. Australian data reveal that
enteric viruses, mainly norovirus and rotavirus,
are the most common causes of non-food gastro-
enteritis, accounting for about 15–18% of all gas-
troenteritis cases [5]. The WHO reported that in
2009, rotavirus was detected in a median of 36%
(range 12–68%) of children aged <5 years hospita-
lised for diarrhoea and were tested for rotavirus
[16]. Previous reports from Australia found norovi-
rus as the most common cause of gastroenteritis
in the community [17,18]. The testing for norovi-
rus only in outbreak settings in one hospital may
have resulted in a testing bias. The incidence of
adenoviruses in this population (21%) is also quite
surprising, since its prevalence is usually signifi-
cantly less than rotavirus. The reason for the high
incidence detected in this study is not particularly
clear. Other reports have found adenovirus rates
ranging from 1.5% to 15% [19,20], although an old-
er report from Sydney found similar rates [21].
The fact that reports from Hospital B, including
non-diarrhoeal adenovirus serotypes, may account
for the overall high prevalence, as has been ob-
served in other studies [22], slightly more were
isolated in Hospital A (24% vs. 20%) which used
the EIA method to detect the enteric serotypes
40/41.
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18 S. Fletcher et al.A major finding was that significantly more ade-
novirus and norovirus were isolated from children
under 1 year old, compared with rotavirus. The
most likely explanation for this is the impact of
the new rotavirus vaccine implemented in 2007.
This vaccine would have covered mainly children
under one year old; hence this age group would have
benefitted from the largest reduction in new cases
[6]. In the Northern Territory, the median age for
non-indigenous Australian children infected with
rotavirus was 16 months old [23]. The introduction
of the rotavirus vaccine for infants has resulted in
an upward shift in the age of children being infected
with rotavirus. Modelling and analysis of post-
vaccination rotavirus rates predict an increase in
the age of first infection, which results in later
onset, fewer cases and less severe symptoms, and
subsequently less hospitalisations [24]. However,
some models have suggested that the incidence of
severe rotaviral infections could increase in older
individuals following vaccine introduction [25]. A
Finnish study also found norovirus to be of similar
prevalence to rotavirus, with infections peaking in
the 0–18 month age group post rotavirus vaccina-
tion [26]. Bacterial infection was less common
(28.7% of cases), and the rate of enteric protozoa
was quite low, emphasising that viral pathogens
are the major causes of childhood diarrhoea in
Sydney. Only a few cases of nosocomial diarrhoeal
illness were observed – the majority of whom were
infected with norovirus. A previous report from
Hospital B found that nearly 15–19% of rotavirus
infectionswere hospital acquired [11]. Other reports
have found norovirus to be the second-most com-
mon cause of nosocomial diarrhoeal infections [4].
There was a clear seasonal distribution of viral
childhood diarrhoea, with winter peaks observed
in this study and which has been confirmed by other
studies in Australia and other parts of the world
[27]. A 20-year-old report described higher rates
of rotavirus in NSW occurring in August and Sep-
tember [28] and more recently from June to
November throughout Australia [6,29]. In temper-
ate climates, rotavirus infections peak in the win-
ter and spring [8], with less obvious seasonal
distribution in tropical countries [30]. While the
seasonal distribution for norovirus was less obvi-
ous, the incidence was highest in winter and is con-
sistent with the wintertime seasonality described
in temperate climates for norovirus [8]. Signifi-
cantly more adenovirus was isolated in autumn.
An older report found that peaks in diarrhoeal ill-
ness in the late summer and early autumn in Sydney
were due to adenovirus infection [21], although a
report from Melbourne found no consistent sea-
sonal distribution [31].
Table 6 Relationship between enteric pathogens, clinical signs and symptoms in hospitalised children, 2007–2010.
Clinical symptoms
(n/300 or 115)
Rotavirus
n (%)
Adenovirus
n (%)
Norovirus
n (%)
P, Pearsons
v2(df)
Campylobacter
spp. n (%)
Salmonella
spp. n (%)
Diarrhoea (286) 93 (32) 100 (35) 93 (33) 0.901, 0.21(2) 59 (52) 55 (48)
Vomiting (211) 86 (41) 65 (31) 60 (28) 0.001, 21.21(2) 34 (49) 35 (51)
Abdominal pain (36) (16) (44) 9 (25) 11 (31) 0.244, 2.82(2) 21 (53) 19 (47)
Fever (160) 70 (44) 51 (32) 39 (24) 0.001, 20.88(2) 38 (48) 42 (52)
Dehydration (102) 52 (51) 30 (29) 20 (20) 0.001, 25.17(2) 12 (46) 14 (54)
Anorexia (92) 43 (47) 34 (37) 15 (16) 0.001, 18.75(2) 17 (49) 18 (51)
Lethargy (128) 54 (42) 42 (33) 32 (25) 0.005, 10.43(2) 14 (47) 16 (53)
Upper respiratory symptoms (84) 24 (29) 32 (38) 28 (34) 0.603, 1.01(2) 10 (48) 11 (52)
Persons with a single virus (rotavirus, adenovirus, norovirus) detected = 300; Campylobacter and Salmonella spp. = 115.
Figure 2 Monthly distribution of viral pathogens associated with childhood diarrhoea in Sydney, 2007–2010.
Gastrointestinal pathogen distribution in symptomatic children in Sydney, Australia 19A gradual decrease in the number of cases of
rotavirus infection was observed after the autumn
of 2008. This dramatic and sustained decline in
the number of cases is most likely attributed to
the introduction of the rotavirus vaccines in July
2007 [32]. The rotavirus vaccination programme
was universally implemented in Australia in the
year 2007 [6,29]. Immunisation against rotavirus
using Rotarix at 2 and 4 months of age started in
the Northern Territory from October 2006, while
universally funded immunisation against rotavirus
at 2 and 4 months of age (Rotarix) or at 2, 4 and6 months of age (Rotateq) began from July 2007
[6]. The effect of the Rotavirus vaccination in
NSW was evident from the obvious decline in cases
from 2008 and 2010 [33]. A reduction of 83% in
South Australia [34], 68% in Queensland notifica-
tions [35], and 70.8% Australia-wide hospitalisa-
tions [36] was observed in rotavirus cases, and
between 33.9% and 48% in all cases [36], following
the introduction of the rotavirus vaccination. An
unexplained increase in the number of cases noted
in the summer of 2010 has also been observed in
Queensland in all age groups as well [35], Careful
20 S. Fletcher et al.attention should therefore be placed at ensuring
that all eligible children are vaccinated, to provide
herd protection for older and younger children not
immunised for various reasons and hence suscepti-
ble [32].
Genotyping is not routinely conducted for en-
teric viruses in NSW hospital laboratories; how-
ever, a fraction of rotavirus-positive specimens
(including some from Hospital B) are submitted to
the Australian Rotavirus Surveillance Programme
in Melbourne for serotyping and have been docu-
mented. Over the mid-2005 to mid-2008 period,
serotype G1 was the most dominant strain identi-
fied nationally and in NSW, followed by serotype
G9 (2005–2007) [37,38], and serotype G2 (2007–
2008) [39]. Genotype analysis from 2008 revealed
that genotype G1P [8] was the most common
nationally and in NSW over the 2008–2011 period,
followed by G3P [8] and G2P [4] in mid-2008–
2009 [40]; and genotype G2P [4] in 2009–2010
[41]. During the period 2010–2011, there was a
shift to the G2P [4] strain being the most common
genotype identified nationally and in NSW, fol-
lowed by G3P [8] [42]. Prior to 1995, rotavirus
genotypes G1P [8], G2P [4], G3P [8] and G4P [8]
were the most common serotype in circulation
worldwide [43,44]. Since then, genotype G9 has in-
creased dramatically and is now considered the
fifth globally important rotavirus genotype
[43,45]. Over the study period, G1 and G1P [8] re-
mained the dominant serotype in the study area,
but a shift to G2P [4] has been observed at the
State and national levels since 2010.
4.1. Limitations
This study, like most retrospective studies, has po-
tential limitations. The difference between the
proportions of pathogens isolated between each
hospital is likely due to the different stool testing
protocols, mainly for the identification of proto-
zoa. In this study, the rate of adenovirus infection
was similar to that of rotavirus and norovirus. It
must be noted that Hospital B used the immuno-
chromatographic test that detects all adenovirus
serotypes and not just the enteric serotypes 40
and 41; hence, a positive result does not necessar-
ily mean the serotype found was the cause of diar-
rhoeal illness. Adenoviruses can cause a broad
spectrum of clinical diseases, most of which are
self-limiting [46], and the rate of isolation in both
hospitals was quite similar (24% vs. 20%). In addi-
tion, testing for norovirus at Hospital A was mainly
when outbreaks were suspected, which may have
resulted in a testing bias. Finally, current clinical
guidelines for the management of acute gastroen-teritis in children do not recommend the routine
collection and testing of stools for an aetiological
agent [47], hence, these cases are likely not repre-
sentative of the full spectrum of paediatric com-
munity gastroenteritis. These results represent
only a sub-section of cases with diarrhoeal illness
that presented to hospital. However, one of these
hospitals is the largest childrens hospital in the
Sydney Childrens hospital network that treats a
large number of children with acute diarrhoea from
across the State whilst the other represents a cul-
turally diverse area in Sydney.
4.2. Conclusion
This study has found that the vast majority of chil-
dren seeking medical attention for diarrhoeal ill-
nesses are infected with an enteric virus. It
highlights the need for careful monitoring and the
rapid assessment and treatment of young children
with gastrointestinal symptoms, especially in the
cooler months. The implementation of a rotavirus
vaccine has proven effective in reducing the inci-
dence of rotavirus infection in young children in
Sydney; hence, attention should be paid to ensur-
ing that all eligible children are vaccinated.
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